Universal-Beteiligungs- und Servicegesellschaft’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio ZNTL Stock Details ZNTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49K	Sell	10,096 -12,351	-55%	-$49.3K	﹤0.01%	2107
2026 Q1	$52.5K	Sell	22,447 -28,614	-56%	-$73.9K	﹤0.01%	2045
2025 Q4	$68.9K	Hold	51,061	–	–	﹤0.01%	2032
2025 Q3	$77.1K	Hold	51,061	–	–	﹤0.01%	2065
2025 Q2	$59.2K	Hold	51,061	–	–	﹤0.01%	1987
2025 Q1	$81.2K	Buy	+51,061	New	+$110K	﹤0.01%	1954

Other funds holding ZNTL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's ZNTL Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Zentalis Pharmaceuticals (ZNTL) stake by 55% in Q2 2026, selling an estimated $49.3K and leaving 10,096 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #2107.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in ZNTL in Q1 2025 and has held it in 6 quarters since. The position peaked at $81.2K in Q1 2025. 48 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 10,096 shares of Zentalis Pharmaceuticals worth $49K as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft sold 12,351 Zentalis Pharmaceuticals shares in Q2 2026, an estimated $49.3K.
Zentalis Pharmaceuticals made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #2107 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Zentalis Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Universal-Beteiligungs- und Servicegesellschaft's Zentalis Pharmaceuticals position peaked at $81.2K in Q1 2025.
48 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.